Cvs Caremark Corp
(CVS-NYSE)
RETAIL - Drug Stores
Stock report updated on 01/20/2012
- CVS is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.
- Volatility is forecast to rise over the next month.
- With RSI > 70, CVS is overbought. Odds slightly favor a short-term price reversal.
- Price broke above prior resistance level - a short-term bullish signal.
| Closing price: |
$42.77 |
| Support price level: |
$38.70 |
| Resistance price level: |
N/A |
| Relative strength index (14-day RSI): |
71.7 |
| Beta: |
0.68 |
52-Week Range
| Low |
High |
Price as % of Range |
| $32.06 |
$43.10 |
97.4% |
Moving Averages
| 200 day |
50 day |
20 day |
10 day |
| $37.00 |
$39.55 |
$41.72 |
$42.28 |
Volatility (annualized std. dev.)
Historical
(5 year) |
Last month |
Current estimate |
Next month forecast |
| 31.9% |
30.8% |
19.5% |
25.1% |
Value at Risk
There is an estimated 5% probability that the stock price of Cvs Caremark Corp will fall by more than:
- 5.3% in the next week.
- 14.2% in the next month.
- 47.5% in the next year.
Company News for Cvs Caremark Corp
Google Finance |
MSN Money |
Reuters
Reports for Other Stocks
